Makita M - Search Results

1

High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas.

Takenaka K, Shinagawa K, Maeda Y, Makita M, Kozuka T, Ashiba A, Yamamoto K, Fujii N, Nawa Y, Hiramatsu Y, Sunami K, Ishimaru F, Yoshimo T, Kiura K, Harada M. Takenaka K, et al. Among authors: makita m. Leuk Lymphoma. 2001 Nov-Dec;42(6):1297-303. doi: 10.1080/10428190127500. Leuk Lymphoma. 2001. PMID: 11911411

2

Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions.

Makita M, Maeda Y, Takenaka K, Shinagawa K, Sunami K, Hiramatsu Y, Fujii N, Ishimaru F, Ikeda K, Niiya K, Yoshino T, Harada M. Makita M, et al. Int J Hematol. 2002 Jul;76(1):94-7. doi: 10.1007/BF02982726. Int J Hematol. 2002. PMID: 12138904

3

The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis.

Nishimori H, Matsuo K, Maeda Y, Nawa Y, Sunami K, Togitani K, Takimoto H, Hiramatsu Y, Kiguchi T, Yano T, Yamane H, Tabayashi T, Takeuchi M, Makita M, Sezaki N, Yamasuji Y, Sugiyama H, Tabuchi T, Kataoka I, Fujii N, Ishimaru F, Shinagawa K, Ikeda K, Hara M, Yoshino T, Tanimoto M; West-Japan Hematology and Oncology Group (West-JHOG). Nishimori H, et al. Among authors: makita m. Int J Hematol. 2009 Apr;89(3):326-331. doi: 10.1007/s12185-009-0259-8. Epub 2009 Mar 27. Int J Hematol. 2009. PMID: 19326060

4

Acute lymphoblastic leukemia with large molecular ACTH production.

Makita M, Maeda Y, Hashimoto K, Nakase K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Ogura T, Harada M. Makita M, et al. Ann Hematol. 2003 Jul;82(7):448-51. doi: 10.1007/s00277-003-0671-8. Epub 2003 May 15. Ann Hematol. 2003. PMID: 12750844

5

Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes.

Makita M, Azuma T, Hamaguchi H, Niiya H, Kojima K, Fujita S, Tanimoto M, Harada M, Yasukawa M. Makita M, et al. Leukemia. 2002 Dec;16(12):2400-7. doi: 10.1038/sj.leu.2402742. Leukemia. 2002. PMID: 12454745

6

[Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].

Ishikawa T, Fukumi T, Moriyama T, Murakami H, Nagakita K, Yoshioka T, Makita M, Shinno Y, Sunami K. Ishikawa T, et al. Among authors: makita m. Rinsho Ketsueki. 2019;60(10):1455-1461. doi: 10.11406/rinketsu.60.1455. Rinsho Ketsueki. 2019. PMID: 31695007 Japanese.

7

Bendamustine Plus Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Low-grade B-cell Lymphoma and Mantle Cell Lymphoma: A Single-Center Retrospective Study.

Murakami H, Yoshioka T, Moriyama T, Ishikawa T, Makita M, Sunami K. Murakami H, et al. Among authors: makita m. Acta Med Okayama. 2021 Aug;75(4):461-469. doi: 10.18926/AMO/62398. Acta Med Okayama. 2021. PMID: 34511613 Free article.

8

A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.

Miura K, Konishi J, Miyake T, Makita M, Hojo A, Masaki Y, Uno M, Ozaki J, Yoshida C, Niiya D, Kitazume K, Maeda Y, Takizawa J, Sakai R, Yano T, Yamamoto K, Sunami K, Hiramatsu Y, Aoyama K, Tsujimura H, Murakami J, Hatta Y, Kanno M. Miura K, et al. Among authors: makita m. Oncologist. 2017 May;22(5):554-560. doi: 10.1634/theoncologist.2016-0260. Epub 2017 Apr 13. Oncologist. 2017. PMID: 28408622 Free PMC article.

9

Angioimmunoblastic T-cell Lymphoma Presenting as a Methotrexate-associated Lymphoproliferative Disorder with Extreme Peripheral Blood Plasmacytosis.

Murakami H, Makita M, Ishikawa T, Yoshioka T, Nagakita K, Shinno Y, Yoshino T, Maeda Y, Sunami K. Murakami H, et al. Among authors: makita m. Intern Med. 2022 Sep 1;61(17):2655-2660. doi: 10.2169/internalmedicine.8422-21. Epub 2022 Feb 8. Intern Med. 2022. PMID: 35135913 Free PMC article.

10

Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study.

Sunami K, Murakami H, Tagashira H, Ueda H, Moriyama T, Ishikawa T, Yoshioka T, Makita M. Sunami K, et al. Among authors: makita m. Int J Clin Oncol. 2020 Dec;25(12):2151-2157. doi: 10.1007/s10147-020-01754-2. Epub 2020 Jul 26. Int J Clin Oncol. 2020. PMID: 32715356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters